Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Andrew S. Rymer

Partner
 
Andrew Rymer is a member of Centerview’s healthcare investment banking team.   He brings nearly 20 years of experience, advising companies on a variety of strategic matters.

Mr. Rymer has established himself as one the leading healthcare advisors, having worked on some of the industry’s largest and most important transactions.  These include: Pfizer’s $68 billion acquisition of Wyeth; Johnson & Johnson’s $21bn acquisition of Synthes; Pfizer’s $14bn acquisition of Medivation and $5.2bn acquisition of Anacor; athenahealth’s $5.7bn sale to Veritas Capital and Evergreen Coast Capital; Merck’s €3.25 billion acquisition of Antelliq Group; Endocyte’s $2.1bn sale to Novartis; Catalent’s $1.2bn acquisition of Paragon Bioservices; Micromet’s $1.2 billion sale to Amgen; NeuroDerm’s $1.1bn sale to Mitsubishi Tanabe; inVentiv’s $1.1 billion sale to TH Lee; Novartis’s $1bn sale of its Sandoz US dermatology and generics business to Aurobindo; Nightstar Therapeutics’ $877mm sale to Biogen; Pfizer’s joint venture with GlaxoSmithKline to create the world’s leading consumer healthcare company; Merck’s worldwide strategic collaboration with Eisai regarding Lenvima; Phillip-Medisize’s sale to Golden Gate Capital; and US Renal’s sale to Leonard Green.

Additionally, Mr. Rymer has executed numerous financing transactions and advisory assignments for a diverse group of industry leaders including Pfizer, Johnson & Johnson, Eli Lilly, Aetna, Wellchoice, Horizon Blue Cross Blue Shield and many of the largest financial sponsors.

Prior to joining Centerview, Mr. Rymer spent 10 years at Goldman Sachs, most recently as a Managing Director with responsibility for the firm’s Healthcare M&A activities.  While at Goldman Sachs, he was asked by the firm’s CEO and President to serve as Head of Client Strategy for 18 months in order to help enhance effectiveness across Goldman’s client footprint.  Mr. Rymer began his career as an investment banking analyst at Donaldson, Lufkin & Jenrette and worked at Credit Suisse upon its acquisition of DLJ.

Mr. Rymer received a B.A., cum laude and with Honors, from Dartmouth College. Mr. Rymer lives in New York City with his wife and three children.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Covia Holdings Corporation
Announced: Q2 2020
Value: $1.6 billion
Status: Pending

Financial advisor to an ad hoc group of Term Loan lenders under Covia's Term Loan facility in connection with its restructuring support agreement and voluntary petitions for reorganization under Chapter 11
View All
New York

Centerview Partners LLC


31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP


100 Pall Mall

3rd Floor

London SW1Y 5NQ

02074099700 | Tel
02074099704 | Fax
Paris

Centerview Partners France SCS


16 Avenue Matignon

4th Floor

Paris 75008

0180200620 | Tel
0180200621 | Fax
Palo Alto

Centerview Partners LLC


600 Ramona St.

Suite 300

Palo Alto, California 94301

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC


555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax





Chicago

Centerview Partners LLC





Los Angeles

Centerview Partners LLC





Copyright © 2008 - 2020 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC